KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Intangibles: 2009-2024

Historic Change in Intangibles for Sarepta Therapeutics (SRPT) over the last 16 years, with Dec 2024 value amounting to $10.0 million.

  • Sarepta Therapeutics' Change in Intangibles was N/A to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2024, which is 90.20% down from last year.
  • Per Sarepta Therapeutics' latest filing, its Change in Intangibles stood at $10.0 million for FY2024, which was down 90.20% from $102.0 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Change in Intangibles ranged from a high of $108.1 million in FY2020 and a low of $1.4 million during FY2022.
  • In the last 3 years, Sarepta Therapeutics' Change in Intangibles had a median value of $10.0 million in 2024 and averaged $37.8 million.
  • Its Change in Intangibles has fluctuated over the past 5 years, first slumped by 98.60% in 2022, then skyrocketed by 7,047.86% in 2023.
  • Yearly analysis of 5 years shows Sarepta Therapeutics' Change in Intangibles stood at $108.1 million in 2020, then decreased by 5.62% to $102.0 million in 2021, then plummeted by 98.60% to $1.4 million in 2022, then skyrocketed by 7,047.86% to $102.0 million in 2023, then tumbled by 90.20% to $10.0 million in 2024.